This identification opens the door to future studies on the role of NAT synthesis in PUFA metabolism, as well as the roles of NATs in pathologies, such as fatty liver disease and diabetes, thus establishing the biological roles of these conserved lipids. Here, BRD2 is linked to fatty liver disease.